Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Atrophy; Geographic Atrophy; Macular Degeneration Phase 2 ClinicalTrials
Eye Diseases; Macular Degeneration; Retinal Degeneration Phase 1 ClinicalTrials
Atrophy; Eye Diseases; Geographic Atrophy; Macular Degeneration; Retinal Degeneration Phase 1 ClinicalTrials
CONTENTS